<DOC>
	<DOCNO>NCT01549938</DOCNO>
	<brief_summary>This feasibility double-blind randomise control trial 32 participant . It evaluate feasibility full trial examine efficacy weekly supplementation cholecalciferol ( vitamin D3 ) relative placebo subsequent frequency severity objectively-verified symptomatic acute respiratory tract infection , overall proportion detect colonisation upper respiratory tract 9 common aetiologic viral pathogen .</brief_summary>
	<brief_title>Cholecalciferol Intervention Prevent Respiratory Infections Study</brief_title>
	<detailed_description>The hypothesis full study : Primary The group treat vitamin D3 significantly low frequency symptomatic respiratory tract infection control . Secondary 1 . Among person detect viral colonisation nasopharynx , treat person low frequency symptomatic respiratory tract infection resultant control . 2 . Treated group significantly less severe symptomatic RTIs control . 3 . Treated group significantly shorter symptomatic RTI duration control . For pilot , cohort 32 healthy young adult satisfy inclusion criterion randomise cholecalciferol supplement identical placebo evaluate daily occurrence RTI symptom evaluate weekly presence respiratory colonisation relevant pathogens use nasopharyngeal swab polymerase chain reaction use select pathogen-specific primer . This pilot demonstrate logistic feasibility propose study design provide preliminary data inform large study undertaken next year .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Vitamin D Deficiency</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Students undertake study MS1 building University Tasmania Medical Sciences Precinct ( 17 Liverpool St Hobart TAS ) full duration May September 2012 Persons use tobacco within 6 month precede study entry Persons use vitamin D ( cholecalciferol ergocalciferol ) supplement calcium supplement within 3 month precede study entry and/or person refuse start take supplement study Persons use immunomodulatory medication , diuretic medication , antiepileptic medication , barbiturate . Persons presently diagnose chronic infectious disease ( e.g . HIV , tuberculosis ) , chronic immune deficiency autoimmune condition , respiratory condition ( e.g . asthma , chronic obstructive pulmonary disease ) . Persons hypersensitive vitamin D .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Vitamin D</keyword>
	<keyword>Cholecalciferol</keyword>
	<keyword>Respiratory tract infection</keyword>
</DOC>